{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:34:21Z","timestamp":1793223261012,"version":"4.5.0"},"reference-count":90,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":2873,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:p>Loss of sensation and increased sensory phenomena are major expressions of varieties of diabetic polyneuropathies needing improved assessments for clinical and research purposes. We provide a neurobiological explanation for the apparent paradox between decreased sensation and increased sensory phenomena. Strongly endorsed is the use of the 10-g monofilaments for screening of feet to detect sensation loss, with the goal of improving diabetic management and prevention of foot ulcers and neurogenic arthropathy. We describe improved methods to assess for the kind, severity, and distribution of both large- and small-fiber sensory loss and which approaches and techniques may be useful for conducting therapeutic trials. The abnormality of attributes of nerve conduction may be used to validate the dysfunction of large sensory fibers. The abnormality of epidermal nerve fibers\/1 mm may be used as a surrogate measure of small-fiber sensory loss but appear not to correlate closely with severity of pain. Increased sensory phenomena are recognized by the characteristic words patients use to describe them and by the severity and persistence of these symptoms. Tests of tactile and thermal hyperalgesia are additional markers of neural hyperactivity that are useful for diagnosis and disease management.<\/jats:p>","DOI":"10.2337\/db13-0352","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T21:33:31Z","timestamp":1382650411000},"page":"3677-3686","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":58,"title":["Assessing Decreased Sensation and Increased Sensory Phenomena in Diabetic Polyneuropathies"],"prefix":"10.2337","volume":"62","author":[{"given":"Peter J.","family":"Dyck","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Rochester Medical Center, Rochester, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Staff","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. James B.","family":"Dyck","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"key":"2022031223080924600_B1","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity","volume":"37","author":"Dyck","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031223080924600_B3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jnnp.46.6.491","article-title":"The natural history of acute painful neuropathy in diabetes mellitus","volume":"46","author":"Archer","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022031223080924600_B4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-7216-9491-7.50011-9","article-title":"The Peripheral Sensory Nervous System: Dorsal Root Ganglion Neurons","volume-title":"Peripheral Neuropathy","author":"Lawson","year":"2005","edition":"4th ed."},{"key":"2022031223080924600_B5","first-page":"1063","article-title":"Quantitative Sensation Testing","volume-title":"Peripheral Neuropathy","author":"Dyck","year":"2005","edition":"4th ed."},{"key":"2022031223080924600_B6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/B978-0-7216-9491-7.50042-9","article-title":"Compound Action Potentials of Sural Nerve in Vitro in Peripheral Neuropathy","volume-title":"Peripheral Neuropathy","author":"Lambert","year":"2005","edition":"4th ed."},{"key":"2022031223080924600_B7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.410190504","article-title":"The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia","volume":"19","author":"Dyck","year":"1986","journal-title":"Ann Neurol"},{"key":"2022031223080924600_B8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jnen\/59.6.525","article-title":"Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN)","volume":"59","author":"Dyck","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022031223080924600_B9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0022-510X(95)00277-9","article-title":"A standard test of heat-pain responses using CASE IV","volume":"136","author":"Dyck","year":"1996","journal-title":"J Neurol Sci"},{"key":"2022031223080924600_B10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/B978-0-7216-9491-7.50043-0","article-title":"Quantitating Overall Neuropathic Symptoms, Impairments, and Outcomes","volume-title":"Peripheral Neuropathy","author":"Dyck","year":"2005","edition":"4th ed."},{"key":"2022031223080924600_B11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.24.2.250","article-title":"Simple screening tests for peripheral neuropathy in the diabetes clinic","volume":"24","author":"Perkins","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B13","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","article-title":"Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy","volume":"25","author":"Bril","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.21661","article-title":"Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial","volume":"42","author":"Dyck","year":"2010","journal-title":"Muscle Nerve"},{"key":"2022031223080924600_B15","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archneurol.2012.1481","article-title":"\u201cUnequivocally abnormal\u201d vs \u201cusual\u201d signs and symptoms for proficient diagnosis of diabetic polyneuropathy: Cl vs N Phys Trial","volume":"69","author":"Dyck","year":"2012","journal-title":"Arch Neurol"},{"key":"2022031223080924600_B16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000658-191708000-00011","article-title":"On the nature of neuropathic affections of the joints","volume":"66","author":"Eloesser","year":"1917","journal-title":"Ann Surg"},{"key":"2022031223080924600_B17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ar.1090750305","article-title":"Influence of the nervous system on bone and joints","volume":"75","author":"Corbin","year":"1939","journal-title":"Anat Rec"},{"key":"2022031223080924600_B18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1302\/0301-620X.48B1.4","article-title":"Patterns of disintegration of the tarsus in the anaesthetic foot","volume":"48","author":"Harris","year":"1966","journal-title":"J Bone Joint Surg Br"},{"key":"2022031223080924600_B19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.33.3.357","article-title":"Neurogenic arthropathy and recurring fractures with subclinical inherited neuropathy","volume":"33","author":"Dyck","year":"1983","journal-title":"Neurology"},{"key":"2022031223080924600_B20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0958-2592(92)90020-P","article-title":"Peripheral neuropathy and the diabetic foot","volume":"2","author":"Boulton","year":"1992","journal-title":"Foot"},{"key":"2022031223080924600_B21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"2022031223080924600_B22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diacare.17.6.557","article-title":"The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study","volume":"17","author":"Young","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B23","volume-title":"What Diabetic Care to Expect","author":"British Diabetic Association","year":"1990"},{"key":"2022031223080924600_B24","first-page":"616","article-title":"Position statement. Standards of medical care for patients with diabetes mellitus","volume":"17","author":"American Diabetes Association","year":"1993","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF00400259","article-title":"The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study","volume":"35","author":"Veves","year":"1992","journal-title":"Diabetologia"},{"key":"2022031223080924600_B26","first-page":"253","article-title":"The predictive value of sensation testing in the development of neuropathic ulceration on the hands of leprosy patients","volume":"65","author":"Kuipers","year":"1994","journal-title":"Lepr Rev"},{"key":"2022031223080924600_B27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.18.1.34","article-title":"Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy","volume":"18","author":"Young","year":"1995","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ptj\/76.1.68","article-title":"Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments","volume":"76","author":"Mueller","year":"1996","journal-title":"Phys Ther"},{"issue":"4","key":"2022031223080924600_B29","first-page":"CD001488","article-title":"Patient education for preventing diabetic foot ulceration","author":"Valk","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031223080924600_B30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1464-5491.2002.00698.x","article-title":"The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort","volume":"19","author":"Abbott","year":"2002","journal-title":"Diabet Med"},{"key":"2022031223080924600_B31","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/diacare.25.11.2010","article-title":"Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?","volume":"25","author":"Carrington","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B32","first-page":"295","article-title":"The Diabetic Foot","volume-title":"Textbook of Diabetic Neuropathy","author":"Boulton","year":"2003"},{"key":"2022031223080924600_B33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jama.289.2.223","article-title":"Pressure ulcer prevention and management","volume":"289","author":"Lyder","year":"2003","journal-title":"JAMA"},{"key":"2022031223080924600_B34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMcp032966","article-title":"Clinical practice. Neuropathic diabetic foot ulcers","volume":"351","author":"Boulton","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031223080924600_B35","author":"Crawford","year":"2007"},{"key":"2022031223080924600_B36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/dc06-1600","article-title":"Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool","volume":"30","author":"Lavery","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B37","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2337\/dc07-0445","article-title":"Risk factors for recurrent diabetic foot ulcers: site matters","volume":"30","author":"Peters","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B38","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/dmrr.833","article-title":"The diabetic foot: grand overview, epidemiology and pathogenesis","volume":"24","author":"Boulton","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031223080924600_B39","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2337\/dc06-2479","article-title":"Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity","volume":"30","author":"Dyck","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-8227(01)00278-9","article-title":"Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic","volume":"54","author":"Olaleye","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031223080924600_B41","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2337\/dc08-0500","article-title":"Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy","volume":"29","author":"Perkins","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B42","first-page":"327","article-title":"Testing of touch-pressure sensation: introduction of the touch-pressure sensogram","volume-title":"Companion to Peripheral Neuropathy. Illustrated Cases and New Developments","author":"Dyck","year":"2010"},{"key":"2022031223080924600_B43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mus.23765","article-title":"A trial of proficiency of nerve conduction: greater standardization still needed","volume":"48","author":"Dyck","year":"2013","journal-title":"Muscle Nerve"},{"key":"2022031223080924600_B44","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.pain.2013.05.047","article-title":"Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus","volume":"154","author":"Backonja","year":"2013","journal-title":"Pain"},{"key":"2022031223080924600_B45","first-page":"331","article-title":"Thermal disk quantitative sensation testing of cooling discrimination","volume-title":"Companion to Peripheral Neuropathy. Illustrated Cases and New Developments","author":"Dyck","year":"2010"},{"key":"2022031223080924600_B46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/B978-0-7216-9491-7.50038-7","article-title":"Nerve Conduction and Needle Electromyograpy","volume-title":"Peripheral Neuropathy","author":"Kimura","year":"2005","edition":"4th ed."},{"key":"2022031223080924600_B47","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"2022031223080924600_B48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/diacare.22.9.1479","article-title":"Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort","volume":"22","author":"Dyck","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2337\/diacare.11.7.592","article-title":"American Diabetes Association; American Academy of Neurology. Consensus statement: report and recommendations of the San Antonio Conference on Diabetic Neuropathy","volume":"11","year":"1988","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"key":"2022031223080924600_B51","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/jnnp.40.11.1072","article-title":"Nerve biopsy and conduction studies in diabetic neuropathy","volume":"40","author":"Behse","year":"1977","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022031223080924600_B52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.apmr.2004.09.011","article-title":"Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"86","author":"England","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"2022031223080924600_B53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mus.22074","article-title":"Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy","volume":"44","author":"Dyck","year":"2011","journal-title":"Muscle Nerve"},{"key":"2022031223080924600_B54","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.47.4.1042","article-title":"Quantitation of epidermal nerves in diabetic neuropathy","volume":"47","author":"Kennedy","year":"1996","journal-title":"Neurology"},{"key":"2022031223080924600_B55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/B978-0-7216-9491-7.50037-5","article-title":"Pathology and quantitation of cutaneous innervation","volume-title":"Peripheral Neuropathy","author":"Kennedy","year":"2005","edition":"4th ed."},{"key":"2022031223080924600_B56","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.45.10.1848","article-title":"Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy","volume":"45","author":"McCarthy","year":"1995","journal-title":"Neurology"},{"key":"2022031223080924600_B57","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/WNL.53.8.1634","article-title":"Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies","volume":"53","author":"Herrmann","year":"1999","journal-title":"Neurology"},{"key":"2022031223080924600_B58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/01.wnl.0000336345.70511.0f","article-title":"Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation","volume":"72","author":"England","year":"2009","journal-title":"Neurology"},{"key":"2022031223080924600_B59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/WNL.16.1.10","article-title":"Quantitation of Meissner\u2019s corpuscles in hereditary neurologic disorders. Charcot-Marie-Tooth disease, Roussy-Levy syndrome, Dejerine-Sottas disease, hereditary sensory neuropathy, spinocerebellar degenerations, and hereditary spastic paraplegia","volume":"16","author":"Dyck","year":"1966","journal-title":"Neurology"},{"key":"2022031223080924600_B60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.10615","article-title":"Quantification of myelinated endings and mechanoreceptors in human digital skin","volume":"54","author":"Nolano","year":"2003","journal-title":"Ann Neurol"},{"key":"2022031223080924600_B61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","article-title":"Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study","volume":"15","author":"Lauria","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"2022031223080924600_B62","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1212\/WNL.0b013e3182759608","article-title":"Epidermal nerve fibers: confidence intervals and continuous measures with nerve conduction","volume":"79","author":"Engelstad","year":"2012","journal-title":"Neurology"},{"key":"2022031223080924600_B63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mus.20732","article-title":"Intraepidermal nerve fiber density as a marker of early diabetic neuropathy","volume":"35","author":"Umapathi","year":"2007","journal-title":"Muscle Nerve"},{"key":"2022031223080924600_B64","author":"Shun","year":"2004"},{"key":"2022031223080924600_B65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1529-8027.2010.00269.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"2022031223080924600_B66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ana.410420509","article-title":"Long-term effects of pancreatic transplantation on diabetic neuropathy","volume":"42","author":"Navarro","year":"1997","journal-title":"Ann Neurol"},{"key":"2022031223080924600_B67","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031223080924600_B68","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mus.10567","article-title":"Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy","volume":"29","author":"Herrmann","year":"2004","journal-title":"Muscle Nerve"},{"key":"2022031223080924600_B69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.WNL.0000070781.92512.A4","article-title":"Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies","volume":"61","author":"Lauria","year":"2003","journal-title":"Neurology"},{"key":"2022031223080924600_B70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1212\/01.wnl.0000194314.86486.a2","article-title":"The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy","volume":"66","author":"Gibbons","year":"2006","journal-title":"Neurology"},{"key":"2022031223080924600_B71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2377-7-11","article-title":"Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy","volume":"7","author":"Facer","year":"2007","journal-title":"BMC Neurol"},{"key":"2022031223080924600_B72","author":"Narayanaswamy","year":"2012"},{"key":"2022031223080924600_B73","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/mus.20098","article-title":"Tubule and neurofilament immunoreactivity in human hairy skin: markers for intraepidermal nerve fibers","volume":"30","author":"Lauria","year":"2004","journal-title":"Muscle Nerve"},{"key":"2022031223080924600_B74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G","article-title":"Multiple measures of axonal excitability: a new approach in clinical testing","volume":"23","author":"Kiernan","year":"2000","journal-title":"Muscle Nerve"},{"key":"2022031223080924600_B75","author":"Krishnan","year":"2005"},{"key":"2022031223080924600_B76","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/db11-1509","article-title":"Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes","volume":"61","author":"Sung","year":"2012","journal-title":"Diabetes"},{"key":"2022031223080924600_B77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/dmrr.2360","article-title":"Axonal dysfunction prior to neuropathy onset in type 1 diabetes","volume":"29","author":"Arnold","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031223080924600_B78","volume-title":"Gunshot Wounds and other Injuries of Nerves","author":"Mitchell","year":"1864"},{"key":"2022031223080924600_B79","doi-asserted-by":"crossref","DOI":"10.1097\/00000441-187207000-00024","volume-title":"Injuries of Nerves and Their Consequences","author":"Mitchell","year":"1872"},{"key":"2022031223080924600_B80","first-page":"225","article-title":"A human experiment in nerve division","volume-title":"Studies in Neurology","author":"Rivers","year":"1920"},{"key":"2022031223080924600_B81","first-page":"778","article-title":"Method of fascicular biopsy of human peripheral nerve for electrophysiologic and histologic study","volume":"41","author":"Dyck","year":"1966","journal-title":"Mayo Clin Proc"},{"key":"2022031223080924600_B82","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/248740a0","article-title":"Properties of afferent nerve impulses originating from a neuroma","volume":"248","author":"Wall","year":"1974","journal-title":"Nature"},{"key":"2022031223080924600_B83","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(79)90002-2","article-title":"Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa","volume":"7","author":"Wall","year":"1979","journal-title":"Pain"},{"key":"2022031223080924600_B84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0304-3959(83)90164-1","article-title":"Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats","volume":"17","author":"Wall","year":"1983","journal-title":"Pain"},{"key":"2022031223080924600_B85","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"2022031223080924600_B86","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0074-7742(02)50078-7","article-title":"Potential mechanisms of neuropathic pain in diabetes","volume":"50","author":"Calcutt","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"2022031223080924600_B87","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tins.2007.08.004","article-title":"From genes to pain: Na v 1.7 and human pain disorders","volume":"30","author":"Dib-Hajj","year":"2007","journal-title":"Trends Neurosci"},{"key":"2022031223080924600_B88","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"2022031223080924600_B89","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/WNL.48.2.501","article-title":"Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans","volume":"48","author":"Dyck","year":"1997","journal-title":"Neurology"},{"key":"2022031223080924600_B90","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2750","article-title":"Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat Med"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/62\/11\/3677\/569000\/3677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/62\/11\/3677\/569000\/3677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:36:17Z","timestamp":1667406977000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/62\/11\/3677\/33895\/Assessing-Decreased-Sensation-and-Increased"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":90,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,10,18]]},"published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db13-0352","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,18]]}}}